Nancy Sweeters

996 total citations
28 papers, 731 citations indexed

About

Nancy Sweeters is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Nancy Sweeters has authored 28 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 14 papers in Hematology and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Nancy Sweeters's work include Hemoglobinopathies and Related Disorders (26 papers), Iron Metabolism and Disorders (13 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Nancy Sweeters is often cited by papers focused on Hemoglobinopathies and Related Disorders (26 papers), Iron Metabolism and Disorders (13 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Nancy Sweeters collaborates with scholars based in United States, Canada and United Kingdom. Nancy Sweeters's co-authors include Elliott Vichinsky, Frans A. Kuypers, Claudia R. Morris, Sandra Larkin, Lori Styles, Lynne Neumayr, Sylvia T. Singer, Nancy F. Olivieri, John B. Porter and Ashutosh Lal and has published in prestigious journals such as Blood, Free Radical Biology and Medicine and Annals of the New York Academy of Sciences.

In The Last Decade

Nancy Sweeters

28 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy Sweeters United States 14 597 445 154 116 84 28 731
Lisa Lavrisha United States 5 203 0.3× 146 0.3× 52 0.3× 198 1.7× 57 0.7× 8 452
Preamrudee Poomthavorn Thailand 15 88 0.1× 76 0.2× 85 0.6× 51 0.4× 125 1.5× 59 626
Xylina T. Gregg United States 6 91 0.2× 99 0.2× 118 0.8× 72 0.6× 42 0.5× 9 398
Faruk Alpay Türkiye 11 78 0.1× 76 0.2× 344 2.2× 99 0.9× 145 1.7× 33 633
C. Roman United States 11 101 0.2× 62 0.1× 186 1.2× 58 0.5× 124 1.5× 19 578
Francesca Cendali United States 11 77 0.1× 57 0.1× 74 0.5× 167 1.4× 119 1.4× 35 413
Thor W.R Hansen United States 13 113 0.2× 53 0.1× 482 3.1× 28 0.2× 219 2.6× 25 665
J. S. Thompson United Kingdom 12 43 0.1× 266 0.6× 22 0.1× 78 0.7× 61 0.7× 25 566
Soodabeh Safai‐Kutti Sweden 13 243 0.4× 258 0.6× 7 0.0× 40 0.3× 147 1.8× 34 469
Caroline Protin France 8 215 0.4× 71 0.2× 32 0.2× 17 0.1× 68 0.8× 19 576

Countries citing papers authored by Nancy Sweeters

Since Specialization
Citations

This map shows the geographic impact of Nancy Sweeters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Sweeters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Sweeters more than expected).

Fields of papers citing papers by Nancy Sweeters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Sweeters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Sweeters. The network helps show where Nancy Sweeters may publish in the future.

Co-authorship network of co-authors of Nancy Sweeters

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Sweeters. A scholar is included among the top collaborators of Nancy Sweeters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Sweeters. Nancy Sweeters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morris, Claudia R., Hae‐Young Kim, Elizabeth S. Klings, et al.. (2015). Dysregulated arginine metabolism and cardiopulmonary dysfunction in patients with thalassaemia. British Journal of Haematology. 169(6). 887–898. 18 indexed citations
2.
Singer, Sylvia T., Frans A. Kuypers, Ginny Gildengorin, et al.. (2014). Elevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy. Annals of Hematology. 93(7). 1139–1148. 16 indexed citations
3.
Harmatz, Paul, Vivian Ng, Patricia Evans, et al.. (2014). Iron Overload and Hemolysis Modulate Monocytes and Inflammation in β-Thalassemia. Free Radical Biology and Medicine. 76. S65–S65. 2 indexed citations
4.
Sweeters, Nancy, et al.. (2013). Treatment of Classic Pantothenate Kinase–Associated Neurodegeneration with Deferiprone and Intrathecal Baclofen. American Journal of Physical Medicine & Rehabilitation. 92(8). 728–733. 18 indexed citations
5.
Morris, Claudia R., John C. Wood, John B. Porter, et al.. (2013). Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension. Haematologica. 98(9). 1359–1367. 33 indexed citations
6.
Morris, Claudia R., Frans A. Kuypers, Lisa Lavrisha, et al.. (2013). A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. Haematologica. 98(9). 1375–1382. 113 indexed citations
7.
Klaassen, Robert J., Nicholas Barrowman, Elliott Vichinsky, et al.. (2013). Validation and reliability of a disease‐specific quality of life measure (the TranQol) in adults and children with thalassaemia major. British Journal of Haematology. 164(3). 431–437. 39 indexed citations
8.
Lal, Ashutosh, John B. Porter, Nancy Sweeters, et al.. (2012). Combined chelation therapy with deferasirox and deferoxamine in thalassemia. Blood Cells Molecules and Diseases. 50(2). 99–104. 73 indexed citations
9.
Morris, Claudia R., Hae-Young Kim, John C. Wood, et al.. (2012). Cardiopulmonary and Laboratory Profiling of Patients with Thalassemia At Risk for Pulmonary Hypertension: Report From the Thalassemia Clinical Research Network.. Blood. 120(21). 2122–2122. 1 indexed citations
10.
11.
Pakbaz, Zahra, Marsha Treadwell, Hae‐Young Kim, et al.. (2010). Education and employment status of children and adults with thalassemia in North America. Pediatric Blood & Cancer. 55(4). 678–683. 12 indexed citations
12.
Singer, Sylvia T., et al.. (2010). Fertility potential in thalassemia major women: current findings and future diagnostic tools. Annals of the New York Academy of Sciences. 1202(1). 226–230. 16 indexed citations
13.
Lal, Ashutosh, Nancy Sweeters, Vivian Ng, et al.. (2010). Combined Chelation Therapy with Deferasirox and Deferoxamine In Transfusion-Dependent Thalassemia. Blood. 116(21). 4269–4269. 1 indexed citations
14.
Morris, Claudia R., et al.. (2009). Arginine Therapy for Vaso-Occlusive Pain Episodes in Sickle Cell Disease.. Blood. 114(22). 573–573. 10 indexed citations
15.
Lal, Ashutosh, et al.. (2009). Safety of Combined Chelation Therapy with Deferasirox and Deferoxamine in Transfusion-Dependent Thalassemia.. Blood. 114(22). 2021–2021. 13 indexed citations
16.
Singer, Sylvia T., Elliott Vichinsky, Sandra Larkin, et al.. (2008). Hydroxycarbamide‐induced changes in E/beta thalassemia red blood cells. American Journal of Hematology. 83(11). 842–845. 19 indexed citations
17.
Singer, Sylvia T., Frans A. Kuypers, Nancy F. Olivieri, et al.. (2005). Fetal haemoglobin augmentation in E/β0 thalassaemia: clinical and haematological outcome. British Journal of Haematology. 131(3). 378–388. 46 indexed citations
18.
Singer, Sylvia T., Frans A. Kuypers, Nancy F. Olivieri, et al.. (2005). Single and Combination Drug Therapy for Fetal Hemoglobin Augmentation in Hemoglobin E‐β0‐Thalassemia: Considerations for Treatment. Annals of the New York Academy of Sciences. 1054(1). 250–256. 13 indexed citations
19.
Morris, Claudia R., Frans A. Kuypers, Sandra Larkin, et al.. (2000). Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease. British Journal of Haematology. 111(2). 498–500. 98 indexed citations
20.
Morris, Carole, Frans A. Kuypers, Sandra Larkin, et al.. (2000). Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease. SHORT REPORT. British Journal of Haematology. 111(2). 498–500. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa Lavrisha Breakdown of academic impact, for papers by Preamrudee Poomthavorn Breakdown of academic impact, for papers by Xylina T. Gregg Breakdown of academic impact, for papers by Faruk Alpay Breakdown of academic impact, for papers by C. Roman Breakdown of academic impact, for papers by Francesca Cendali Breakdown of academic impact, for papers by Thor W.R Hansen Breakdown of academic impact, for papers by J. S. Thompson Breakdown of academic impact, for papers by Soodabeh Safai‐Kutti Breakdown of academic impact, for papers by Caroline Protin
Rankless by CCL
2026